ACGT Research Fellow, Dr. Alexander Stegh, said, “My research group is working to uncover the secrets of cancer and, more importantly, how to stop it.”
Stegh added, “Glioblastoma is a very challenging cancer, and most chemo-therapeutic drugs fail in the clinic. The beauty of the gene we silenced in this study is that it plays many different roles in therapy resistance. Taking the gene out of the picture should allow conventional therapies to be more effective.”